Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study
/in Breast Cancer, Dendritic Cells, International Publications, IOZK Veröffentlichungen /von 2008-11-08 / Cancer Immunol. Immunother. 2009 Jun;58(6):887-900Short-term activation induces multifunctional dendritic cells that generate potent antitumor T-cell responses in vivo
/in Dendritic Cells, International Publications /von 2008-10-25 / Cancer Immunol. Immunother. 2009 Jun;58(6):901-13The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience
/in Acute Leukemia, Dendritic Cells, International Publications /von 2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-67Cancer immunotherapy by dendritic cells
/in Dendritic Cells, International Publications /von 2008-09-19 / Immunity 2008 Sep;29(3):372-83Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy
/in Dendritic Cells, International Publications /von 2008-09-01 / J. Immunother. 2008 Sep;31(7):620-32Novel therapeutic strategies for treating esophageal adenocarcinoma: the potential of dendritic cell immunotherapy and combinatorial regimens
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2008-08-12 / Hum. Immunol. 2008 Oct;69(10):614-24Dendritic cell vaccines in metastasized malignant melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2008-08-01 / G Ital Dermatol Venereol 2008 Aug;143(4):235-50Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients
/in Dendritic Cells, Glioblastoma, International Publications /von 2008-07-15 / Cancer Res. 2008 Jul;68(14):5955-64Alterations in p53-specific T cells and other lymphocyte subsets in breast cancer patients during vaccination with p53-peptide loaded dendritic cells and low-dose interleukin-2
/in Breast Cancer, Dendritic Cells, International Publications /von 2008-07-09 / Vaccine 2008 Aug;26(36):4716-24
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de